Quarterlytics / Industries / Healthcare / Biotechnology
Industry
Healthcare

Biotechnology

446 companies in this industry — from early-stage micro-caps to established names the market already covers.

446companies 30pages Healthcare
Companies covered 446
Sector Healthcare
Industry Biotechnology
Latest filing
Coverage Updated weekly
Exchange Sort
Showing 15 of 446 companies Page 18 of 30
LIXT NASDAQ · 2 emp.

Lixte Biotechnology Holdings, Inc.

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common...

Biotechnology
MAZE NASDAQ · 125 emp.

Maze Therapeutics, Inc.

Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, ...

Biotechnology
CRBU NASDAQ · 147 emp.

Caribou Biosciences, Inc.

Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatmen...

Biotechnology
CCCC NASDAQ · 110 emp.

C4 Therapeutics, Inc.

C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatmen...

Biotechnology
DMRA NASDAQ · 7 emp.

Galecto, Inc.

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biolog...

Biotechnology
GNLX NASDAQ · 24 emp.

Genelux Corporation

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering...

Biotechnology
LYEL NASDAQ · 300 emp.

Lyell Immunopharma, Inc.

Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapi...

Biotechnology
LXEO NASDAQ · 75 emp.

Lexeo Therapeutics, Inc. Common Stock

Lexeo Therapeutics, Inc. operates as a clinical-stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006,...

Biotechnology
VOR NASDAQ · 159 emp.

Vor Biopharma Inc.

Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an e...

Biotechnology
GANX NASDAQ · 23 emp.

Gain Therapeutics, Inc.

Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare ...

Biotechnology
TLSA NASDAQ · 9 emp.

Tiziana Life Sciences Ltd

Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology....

AKTS NASDAQ · 79 emp.

Aktis Oncology, Inc.

Aktis Oncology, Inc. operates as a clinical-stage oncology company that engages in the development of targeted radiopharmaceutical therapies for cancer treat...

EPRX NASDAQ · 33 emp.

Eupraxia Pharmaceuticals Inc.

Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnol...

Biotechnology
MGTX NASDAQ · 375 emp.

MeiraGTx Holdings plc

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops vari...

BIOA NASDAQ · 62 emp.

BioAge Labs, Inc.

BioAge Labs, Inc. is a clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology...

Biotechnology
1 17 18 19 30
Healthcare · Biotechnology coverage

The whole industry,
in one read.

We publish original research across all biotechnology companies — profiles, earnings reports and news on the small- and mid-caps the market overlooks. 446 companies, permanently indexed. Free to read.

All Healthcare companies Browse all industries →
Editorial photograph